These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27054931)

  • 1. Ondansetron Use in Pregnancy.
    Siminerio LL; Bodnar LM; Venkataramanan R; Caritis SN
    Obstet Gynecol; 2016 May; 127(5):873-877. PubMed ID: 27054931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran).
    Tincello DG; Johnstone MJ
    Postgrad Med J; 1996 Nov; 72(853):688-9. PubMed ID: 8944215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gabapentin on hyperemesis gravidarum: a double-blind, randomized controlled trial.
    Guttuso T; Messing S; Tu X; Mullin P; Shepherd R; Strittmatter C; Saha S; Thornburg LL
    Am J Obstet Gynecol MFM; 2021 Jan; 3(1):100273. PubMed ID: 33451591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intractable hyperemesis gravidarum by ondansetron.
    Siu SS; Yip SK; Cheung CW; Lau TK
    Eur J Obstet Gynecol Reprod Biol; 2002 Oct; 105(1):73-4. PubMed ID: 12270570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of intravenous ondansetron for hyperemesis gravidarum.
    Sullivan CA; Johnson CA; Roach H; Martin RW; Stewart DK; Morrison JC
    Am J Obstet Gynecol; 1996 May; 174(5):1565-8. PubMed ID: 9065130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating the effect of Ondansetron and Mirtazapine In Treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial.
    Ostenfeld A; Petersen TS; Futtrup TB; Andersen JT; Jensen AK; Westergaard HB; Pedersen LH; Løkkegaard ECL
    BMJ Open; 2020 Mar; 10(3):e034712. PubMed ID: 32209630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis.
    Boelig RC; Barton SJ; Saccone G; Kelly AJ; Edwards SJ; Berghella V
    J Matern Fetal Neonatal Med; 2018 Sep; 31(18):2492-2505. PubMed ID: 28614956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial.
    Abas MN; Tan PC; Azmi N; Omar SZ
    Obstet Gynecol; 2014 Jun; 123(6):1272-1279. PubMed ID: 24807340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States.
    Fejzo MS; MacGibbon KW; Mullin PM
    Reprod Toxicol; 2016 Jul; 62():87-91. PubMed ID: 27151373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaining Insight Into Ondansetron Safety in Early Pregnancy.
    Lavecchia M; Chari R; Ross S
    J Obstet Gynaecol Can; 2019 Apr; 41(4):419-420. PubMed ID: 30685231
    [No Abstract]   [Full Text] [Related]  

  • 11. Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review.
    Lavecchia M; Chari R; Campbell S; Ross S
    J Obstet Gynaecol Can; 2018 Jul; 40(7):910-918. PubMed ID: 29754832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of management approaches for hyperemesis gravidarum and nausea and vomiting of pregnancy: a retrospective questionnaire analysis.
    Mares R; Morrow A; Shumway H; Zapata I; Forstein D; Brooks B
    BMC Pregnancy Childbirth; 2022 Aug; 22(1):609. PubMed ID: 35915406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment.
    O'Donnell A; McParlin C; Robson SC; Beyer F; Moloney E; Bryant A; Bradley J; Muirhead C; Nelson-Piercy C; Newbury-Birch D; Norman J; Simpson E; Swallow B; Yates L; Vale L
    Health Technol Assess; 2016 Oct; 20(74):1-268. PubMed ID: 27731292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expert consensus from the College of French Gynecologists and Obstetricians: Management of nausea and vomiting of pregnancy and hyperemesis gravidarum].
    Deruelle P; Sentilhes L; Ghesquière L; Desbrière R; Ducarme G; Attali L; Jarnoux A; Artzner F; Tranchant A; Schmitz T; Sénat MV
    Gynecol Obstet Fertil Senol; 2022 Nov; 50(11):700-711. PubMed ID: 36150647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label use of ondansetron in pregnancy in Western Australia.
    Colvin L; Gill AW; Slack-Smith L; Stanley FJ; Bower C
    Biomed Res Int; 2013; 2013():909860. PubMed ID: 24396830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes.
    Masarwe S; Shvartsur R; Hadar E; Betesh-Abay B; Peleg N; Azab AN
    Clin Nurs Res; 2023 May; 32(4):705-711. PubMed ID: 36912091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
    Moussa G; Genest M; Villeneuve E; Wang JJ
    Ann Emerg Med; 2021 May; 77(5):555. PubMed ID: 33902836
    [No Abstract]   [Full Text] [Related]  

  • 18. Publishing negative findings and the challenge of avoiding type II errors in studies of suspect teratogens: Example of a recent ondansetron publication.
    Edlavitch SA
    Reprod Toxicol; 2017 Jan; 67():125-128. PubMed ID: 27988282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron use during pregnancy: a case series.
    Ferreira E; Gillet M; Lelièvre J; Bussières JF
    J Popul Ther Clin Pharmacol; 2012; 19(1):e1-e10. PubMed ID: 22267256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetrone or metoclopromide? Which is more effective in severe nausea and vomiting of pregnancy? A randomized trial double-blind study.
    Kashifard M; Basirat Z; Kashifard M; Golsorkhtabar-Amiri M; Moghaddamnia A
    Clin Exp Obstet Gynecol; 2013; 40(1):127-30. PubMed ID: 23724526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.